TK & Partners is a private venture capital firm investing in early-stage deep tech healthcare startups

Beyond financial backers, we’re a committed growth partner

We’re hungry for game-changing ideas. We turn these into reality faster and with less risk through strategy and expertise, capital, people, execution and market access.

Partnerships for success: building the future together

We supercharge new corporate growth through unlocking fresh opportunities and delivering extraordinary returns.

At TKP, we invest in great potential

In the last 5 years, we have invested in 34 startups globally.

We are proud to be an active player in the journey

Welcoming our newest Business Analysts and Summer Interns to TKPartners.

We start with what matters most: learning how to think

We’re excited to announce our investment in Nephrogen, a US-based biotech startup developing next-generation delivery platforms for hard-to-reach organs like the kidney

We are excited to announce our investment as a lead investor in Acurion Health

Acurion is building AI that reads standard pathology slides to help identify key biomarkers faster, at lower cost, and within existing clinical workflows

We’re excited to announce our third investment of 2026: Sonalasense

SonALAsense is developing ALA sonodynamic therapy (SDT), a non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other aggressive cancers.

The TKP team had the pleasure of hosting the Bangchak Corporation PCL, Bangchak Initiative and Innovation Center, and their Management Trainee cohort for an in-depth knowledge-sharing session

Announcing TKP’s first health-tech investment of 2026: Oncoustics

Oncoustics enables fast, non-invasive liver screening and diagnosis in about 5 minutes using AI and hand-held ultrasound devices

As we look toward 2026, our focus remains clear: backing healthcare and HealthTech companies that deliver real clinical value, defensible innovation, and scalable impact across the patient journey.

TKP is excited to announce our investment in Vistim Labs

Vistim’s FDA-registered platform turns standard EEG signals into high-resolution, PET-quality brain maps without radiation, high costs, or long wait times.

A year full of learning for Interns at TKP

At TK Partners, we believe in building people, not just portfolios.

Our internship program is grounded in close mentorship, meaningful ownership, and real exposure to both due diligence and scaling portfolio companies.

A simple dinner, a full room, and a lot of gratitude.

This year gave us plenty to build on—and tonight was a reminder that everything we do is powered by people: our team, our founders, our partners, and the wider ecosystem around us.

Our team had a fantastic time at the Healthspan Festival 2026. One message came through clearly: Thailand has the ingredients to build real health innovation leadership

TKP is excited to announce our investment in Advanced NanoTherapies (ANT), a next-generation vascular medtech company advancing drug-coated balloon technology.

We are excited to have joined GITEX DigiHealth & Biotech Thailand 2025!

Both hardware and software were in the spotlight — and this year, TKP is focusing on healthcare innovation.

As part of our business accelerator program, we are excited to see our portfolio company ArcFusion showcasing at Techsauce Global Summit 2025 for the very first time. We believe in ArcFusion’s strong growth trajectory and their mission to shape the future of AI in the region.

We’re excited to announce our recent investment in AdraVision, an innovative dental automation suite revolutionising the industry.

We’re proud to share that we are one of the key investors in HYDGEN. A developer of next-generation AEM electrolyzers to enable scalable, cost-efficient, and decentralised green hydrogen production.

Our team engaged in a productive training and networking session, strengthening collaboration and enhancing our collective expertise in driving business success.

Discover how Arcfusion is shaping the future of Advertising Analytics through its pioneering solutions that drive efficiency and innovation in the built environment.

We concluded RFO’s Q3 board meeting with valuable discussions on scaling strategies and future initiatives, aligning with our shared vision for sustainable growth.

Our team visited Ackcio’s facilities to explore its cutting-edge industrial IoT solutions, reinforcing our commitment to supporting industry-transforming technologies.

We’re excited to announce RFO’s successful top-up investment, fueling its growth and expansion plans as it continues making strides in the energy and infrastructure sectors.

We proudly welcomed our latest group of talented interns, offering them a dynamic learning experience and real-world exposure in the investment industry.

Explore how SIPGOOD, our portfolio company, is advancing natural wellness through its innovative plant-based products that promote a healthier lifestyle.

Discover the remarkable strides of Hydroneo, our portfolio company, as they revolutionize the Thai shrimp farming sector with innovative smart farming techniques.

Join us in celebrating the remarkable achievement of Seaplane Asia Limited as they expand into Cambodia through the establishment of the joint venture, Samra Seaplane.

Embark on a journey through the latest advancements in cancer treatment as I share my eye-opening experience visiting one of our portfolio companies in Singapore.